SEMIGRAN MARC (Chief Medical Officer) received a stock award from RENOVACOR, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/26/2022ACC: 0000899243-22-003302
Officer· Chief Medical Officer
Since Sep 2021
+52.27K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
52.27K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+17.43K
Price / share
—
Trade value
—
% of position
49.5%
1/24/2022
35.23K→52.65K
Total
Net shares
+17.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/24/2022 | A · Award | +17.43K | — | — | 49.5% | 35.23K | 52.65K |
| Total | +17.43K | $0.00 | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
34.85K shares
Shares
+34.85K
Strike price
6.45
Held after
34.85K
Exercisable
—
1/24/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock34.85K shares | 1/24/2022 | A · Award | +34.85K | 6.45 | — | 34.85K |